Clinical Trial Update: A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether Ide-cel (idecabtagene vicleucel) can be manufactured from patients with multiple myeloma who have previously undergone hemat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Abecma (idecabtagene vicleucel)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING